Ronald Muhlenkamp
Muhlenkamp & Co
Muhlenkamp & Co Portfolio 13F
Ronald Muhlenkamp Holdings Activity
- Portfolio value:
- $213.55M≈ (-$74M≈)
- Previous value:
- $287.15M≈
- # of changes:
- 32
- New positions:
- 0
- Reported for:
- 30 Jun 2022 (Q2)
- Latest filing date:
- 18 Jul 2022
Muhlenkamp & Co has disclosed a total of 32 changes to the portfolio in the (2022 Q2) SEC report(s): increased the number of shares of 5, decreased the number of shares of 19 and completely sold out 8 position(s).
What stocks did Ronald Muhlenkamp buy in 2022 Q2?
During 2022 Q2 Ronald Muhlenkamp has purchased 5 securities: (UNH) UnitedHealth Group Incorporated (added shares +0.18%), (BRK-B) Berkshire Hathaway Inc (added shares +0.21%), (BMY) Bristol-Myers Squibb Company (added shares +0.51%), (FNV) Franco-Nevada Corp (added shares +0.68%) and (RGLD) Royal Gold Inc (added shares +0.67%).
32 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Franco-Nevada Corp
|
+0.68%
|
+240
|
35,453
|
+0.01%
|
$131.58
|
+62.52%($213.85)
|
2.18%
|
2020 Q4
|
≈ 1.75 years
|
|
|
|
Royal Gold Inc
|
+0.67%
|
+279
|
42,103
|
+0.01%
|
$106.79
|
+87.73%($200.47)
|
2.11%
|
2020 Q4
|
≈ 1.75 years
|
|
|
|
Bristol-Myers Squibb Company
|
+0.51%
|
+650
|
127,556
|
+0.02%
|
$77.00
|
-16.63%($64.20)
|
4.60%
|
2019 Q4
|
≈ 2.50 years
|
|
|
|
Berkshire Hathaway Inc
|
+0.21%
|
+78
|
37,194
|
+0.01%
|
$273.03
|
+88.36%($514.28)
|
4.76%
|
2019 Q3
|
≈ 2.75 years
|
|
|
|
UnitedHealth Group Incorporated
|
+0.18%
|
+43
|
24,524
|
+0.01%
|
$513.62
|
-18.89%($416.59)
|
5.90%
|
2016 Q1
|
≈ 6.00 years
|
|
|
|
CVS Health Corp
|
-0.10%
|
-114
|
108,923
|
-0%
|
$92.66
|
+13.32%($105.00)
|
4.73%
|
2019 Q3
|
≈ 2.75 years
|
|
|
|
Alerian MLP ETF
|
-0.21%
|
-593
|
281,100
|
-0.01%
|
$34.45
|
+59.53%($54.96)
|
4.53%
|
2018 Q1
|
≈ 4.00 years
|
|
|
|
Microsoft Corp
|
-0.24%
|
-74
|
31,241
|
-0.01%
|
$256.84
|
+89.20%($485.94)
|
3.76%
|
2013 Q2 or earlier
|
≈ 8.75+ years
|
|
|
|
Schlumberger NV
|
-0.24%
|
-754
|
310,543
|
-0.01%
|
$35.76
|
+37.75%($49.26)
|
5.20%
|
2020 Q4
|
≈ 1.75 years
|
|
|
|
Occidental Petroleum Corp
|
-0.28%
|
-645
|
231,962
|
-0.01%
|
$58.88
|
-5.38%($55.71)
|
6.40%
|
2022 Q1
|
≈ 0.50 years
|
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.